Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300074389Phase 4Recruiting
Phase 4, randomised trial of dexamethasone and lidocaine in breast cancer and stomatitis (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Incidence of grade 2 or above oral mucositis. Started Aug 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300074389.